In modern healthcare, digital prescribing systems must balance clinical accuracy, safety, and interoperability. One of the most fundamental, yet often misunderstood, distinctions in this space is between dose-based and product-based prescribing. This Learning Program explores the core principles, implications, and system design choices associated with each approach, empowering professionals to make informed decisions when designing, implementing, or optimising EPMA systems. Dose-based prescribing centres around prescribing a dose in clinical terms (e.g., “500 mg IV twice daily”), enabling flexibility and alignment with clinical thinking. In contrast, product-based prescribing focuses on specific, coded pharmaceutical products (e.g., a branded vial or pack), offering precision and clear linkage to inventory and dispensing systems. Each has its own strengths and challenges, especially when navigating complex areas such as infusion protocols, paediatrics, or decision support. This program is designed for pharmacy informatics professionals, clinical system designers, and EPMA leads who want to understand: - Why and when each method is used - How they affect workflows and safety - What role national standards (e.g., dm+d) play in prescribing models - How these approaches influence interoperability, automation, and stock management Through structured content, real-world examples, and reflection activities, this program will give you the tools to critically evaluate your organisation’s current setup and explore optimisation opportunities that align with strategic goals.